Field Guide: Interactions

Acarbose alone rarely causes low blood sugar, but combined with insulin or a sulfonylurea it can, and any resulting low must be treated with glucose (dextrose), not table sugar, because acarbose slows the breakdown of table sugar into usable glucose. Digestive enzyme supplements and intestinal adsorbents reduce its effect, and it can lower digoxin levels. Confirm anything specific with your pharmacist.

• ● insulin and sulfonylureas (antidiabetic) : hypoglycemia, and the low must be corrected with glucose (dextrose) because acarbose delays digestion of sucrose (table sugar) into usable glucose. the companion drug may need a lower dose, and lows must be treated with glucose tablets rather than table sugar or fruit juice. [Precose (acarbose) US Prescribing Information, Warnings and Drug Interactions]
• ● digestive enzyme preparations (pancreatin, amylase) and intestinal adsorbents (activated charcoal) (digestive enzymes / intestinal adsorbents) : reduced acarbose effect. avoid taking these together with acarbose. [Precose (acarbose) US Prescribing Information, Warnings and Drug Interactions]
• ● digoxin (cardiac glycoside) : lower digoxin levels and possible loss of effect. monitor digoxin levels; a dose adjustment may be needed. [Precose (acarbose) US Prescribing Information, Warnings and Drug Interactions]

Well tolerated by most people in short trials, but with documented cautions: rare liver injury seen in case series, contraindicated in pregnancy and around conception, immune-stimulating so care is needed with autoimmune disease and immunosuppressants, it can raise thyroid hormone levels, and it adds to sedatives and alcohol.

• ● other hepatotoxic drugs and alcohol (hepatotoxic agents) : risk of liver injury. avoid in existing liver disease; stop and seek care if jaundice, dark urine or abdominal pain develop. [Bjornsson 2020]
• ● immunosuppressant medication (immunosuppressant) · theoretical : may reduce the effect of immunosuppressant therapy or worsen an autoimmune condition. avoid with immunosuppressant therapy or autoimmune disease unless cleared by the clinician managing that condition. [Natural Medicines Comprehensive Database]
• ● thyroid hormone medication (thyroid hormone) : additive with thyroid medication, with a risk of thyroid hormone excess; also relevant in existing thyroid disease. monitor thyroid function and discuss with the clinician managing thyroid treatment. [Natural Medicines Comprehensive Database]
• ● sedatives, benzodiazepines, sleep medicines and alcohol (sedative / CNS depressant) · theoretical : more sedation than intended. use caution combining, and stop ashwagandha well before planned surgery and tell the anaesthetist. [Natural Medicines Comprehensive Database]

Berberine inhibits CYP3A4 and P-glycoprotein, the enzyme and transporter that clear a large share of medicines, so it can raise the blood levels of many prescription drugs, and it adds to glucose-lowering medication. It is contraindicated in pregnancy, breastfeeding and newborns, and in G6PD deficiency, because it can raise free bilirubin and break down red blood cells.

• ● cyclosporine (immunosuppressant (calcineurin inhibitor)) : raised cyclosporine blood levels, by roughly a quarter in transplant patients, which is a meaningful shift for a narrow-margin drug. avoid; if used at all, only with the transplant team and cyclosporine level monitoring. [Wu 2005]
• ● tacrolimus (immunosuppressant (calcineurin inhibitor)) · theoretical : raised tacrolimus blood levels. avoid unless managed with drug-level monitoring by the transplant team. [Natural Medicines Comprehensive Database]
• ● CYP3A4 and P-glycoprotein substrate drugs (CYP3A4 / P-glycoprotein substrates) : increased blood levels of the co-administered drug and a higher risk of its side effects. clear berberine with a prescriber or pharmacist before combining it with any prescription drug, especially a narrow-margin one. [Natural Medicines Comprehensive Database]
• ● insulin, sulfonylureas and other glucose-lowering drugs (antidiabetic) : blood sugar can fall too far, into hypoglycemia. start and dose berberine with the clinician managing diabetes, with blood-sugar monitoring, so the medication can be adjusted. [Lan 2015]
• ● warfarin (anticoagulant) : altered anticoagulation and bleeding risk. monitor INR with a clinician; warfarin is a narrow-margin drug. [Natural Medicines Comprehensive Database]

Inhibits several CYP450 liver enzymes, so it can raise the blood levels of many co-taken drugs; documented interactions with clobazam and warfarin, plus a dose-related liver-enzyme signal that is worse alongside valproate. Check the full medication list with a pharmacist before combining, especially with any narrow-therapeutic-index drug.

• ● clobazam (anticonvulsant (benzodiazepine)) : increased clobazam exposure with more sedation and side effects. monitor for sedation; a clobazam dose reduction is often needed under the prescriber. [Geffrey 2015]
• ● warfarin (anticoagulant) : increased anticoagulant effect and bleeding risk. monitor INR closely; a warfarin dose reduction has been required after starting and titrating CBD. [Cortopassi 2020 (case report)]
• ● valproate (anticonvulsant) : elevated liver enzymes / hepatocellular injury signal. baseline and periodic liver-function testing; this concomitant risk is built into prescription CBD monitoring. [Devinsky 2017]
• ● CYP450 substrate drugs (CYP3A4 / CYP2C19 / CYP2C9) (various narrow-therapeutic-index substrates) : raised blood levels of substrate drugs. review the full medication list with a pharmacist before starting; special care with narrow-therapeutic-index drugs. [Brown 2019 (review)]

The safety point that matters most is bleeding: ginkgo thins the blood, and spontaneous bleeding, including intracranial and intraocular, is documented in people taking it, so it is high-stakes with anticoagulants, antiplatelets and around surgery. It has modest effects on some CYP enzymes, and the raw seed (not the leaf extract) contains a seizure-provoking compound.

• ● warfarin, aspirin, clopidogrel and other anticoagulants/antiplatelets (anticoagulant / antiplatelet) : increased bleeding risk, with documented cases of spontaneous bleeding including into the eye and the brain. treat as something to clear with a clinician first; it is standard to stop ginkgo one to two weeks before planned surgery or a dental procedure. [Bent 2005]
• ● CYP450 substrates (CYP substrate (e.g. CYP2C19)) · theoretical : possible altered levels of some CYP-metabolised drugs, mostly minor. note it with narrow-therapeutic CYP2C19 substrates; discuss with a pharmacist. [Zadoyan 2012 (EGb761 CYP cocktail study)]
• ● anticonvulsants and seizure-threshold-lowering drugs (anticonvulsant) · theoretical : theoretical reduction of seizure control, mainly a concern with the seed or whole nut rather than the standardized leaf extract. people prone to seizures should avoid ginkgo seeds, prefer a standardized leaf extract, and tell their clinician. [Kajiyama 2020 (ginkgo nut seizure case report)]

GLP-1 drugs lower blood sugar, so combining them with insulin or a sulfonylurea can cause hypoglycemia and usually means the prescriber lowers those doses. They slow gastric emptying, which can change how fast oral medicines are absorbed, and tirzepatide can reduce the effectiveness of oral contraceptives around each dose increase. Pancreatitis and gallbladder disease are label warnings rather than drug interactions. Confirm anything specific with your pharmacist.

• ● insulin (insulin) : increased risk of hypoglycemia. the prescriber usually lowers the insulin dose and monitors blood sugar. [Ozempic (semaglutide) US Prescribing Information, Drug Interactions]
• ● sulfonylureas (glipizide, glyburide, glimepiride) (insulin secretagogue) : increased risk of hypoglycemia. the prescriber usually reduces the sulfonylurea dose. [Ozempic (semaglutide) US Prescribing Information, Drug Interactions]
• ● oral medications (delayed gastric emptying) (oral drugs, especially narrow-therapeutic-index) : altered absorption of some oral drugs. monitor drugs where timing or level matters and confirm with a pharmacist. [Ozempic (semaglutide) US Prescribing Information, Drug Interactions]
• ● oral contraceptives (hormonal contraceptive) : reduced contraceptive effectiveness. the tirzepatide label advises a non-oral method, or an added barrier method, for 4 weeks after starting and after each dose increase. [Mounjaro / Zepbound (tirzepatide) US Prescribing Information, Drug Interactions]

Very safe for most people, with one interaction that matters: case reports and pharmacovigilance data link glucosamine, alone or with chondroitin, to a raised INR in people on warfarin. An early worry that this sugar-based molecule might raise blood sugar was not borne out by a controlled trial of the oral supplement. Confirm with your pharmacist.

• ● warfarin (anticoagulant (vitamin K antagonist)) : increased INR and bleeding risk. do not start glucosamine or chondroitin without telling the clinician who manages your warfarin, so your INR can be watched. [Knudsen 2008 (Pharmacotherapy)]
• ● diabetes medications (antidiabetic) · theoretical : no clinically meaningful change in blood sugar at standard oral doses. if you have diabetes it is reasonable to monitor glucose when starting, but the oral evidence is reassuring. [Glucosamine and chondroitin page, Cautions (diabetes and blood sugar)]

Hyperbaric oxygen has few pharmacologic interactions, but the genuine ones matter: high-pressure oxygen can increase the toxicity of certain chemotherapy agents, most clearly bleomycin. An untreated pneumothorax (a collapsed lung) is a separate physical contraindication, not a drug interaction. Confirm any concurrent chemotherapy with the oncology and hyperbaric teams.

• ● bleomycin (chemotherapy (antitumor antibiotic)) : increased risk of pulmonary toxicity. avoid hyperbaric oxygen in people with recent or prior bleomycin exposure unless a specialist judges it necessary. [Sadri 2025, StatPearls]
• ● doxorubicin (chemotherapy (anthracycline)) · theoretical : possible increased toxicity. raise concurrent anthracycline use with the oncology team before treatment. [Sadri 2025, StatPearls]

Sea moss is one of the most concentrated iodine sources there is, and the dose per portion is high and unpredictable. Stacking it with other iodine or using it alongside a thyroid condition or thyroid medication can push the thyroid either way. Amount and sourcing decide whether it helps. Confirm with your pharmacist.

• ● other iodine sources (kelp tablets, iodine drops, iodine-containing multivitamins) : iodine excess can push the thyroid into overactivity or underactivity. keep portions small, do not combine sea moss with other iodine supplements, and favour a product that states a tested iodine figure; adults need about 150 micrograms of iodine a day. [Irish sea moss page, Cautions (the iodine dose is variable and often high)]
• ● thyroid medications and existing thyroid conditions (thyroid medication) : unpredictable thyroid function, with palpitations, weight change, or heat and cold intolerance. if you have a thyroid condition, are pregnant, or are breastfeeding, clear sea moss with your clinician before using it. [Irish sea moss page, Cautions (iodine excess can disrupt the thyroid)]

Even at low doses naltrexone blocks opioid receptors, so it cannot be combined with opioid pain medicines: it blocks their effect and can trigger acute withdrawal in anyone dependent on opioids. This is the central safety point and the reason it is a prescriber's decision, especially around planned surgery. It is processed by the liver and carries caution in significant liver disease. Confirm anything specific with your pharmacist.

• ● opioid medicines (morphine, oxycodone, hydrocodone, fentanyl, tramadol, codeine, methadone, buprenorphine, and opioid-containing cough or antidiarrheal products) (opioid) : blocks opioid pain relief and can precipitate acute opioid withdrawal in a person who is opioid dependent. do not combine; an opioid-free interval is needed before starting, and surgery or emergency pain care must be planned with the prescriber. [Naltrexone (ReVia / Vivitrol) US Prescribing Information, Warnings and Contraindications]
• ● hepatotoxic medicines and significant liver disease (hepatotoxic drugs) · theoretical : potential added liver strain. caution in significant liver disease, and a prescriber reviews the full medication list. [Naltrexone (ReVia / Vivitrol) US Prescribing Information, Warnings and Contraindications]

On its own metformin rarely causes low blood sugar, but with insulin or a sulfonylurea it can. The serious concern is lactic acidosis, which is why the drug is held before iodinated contrast scans and around serious illness. Alcohol and carbonic anhydrase inhibitors add to that risk, some kidney-cleared drugs raise metformin levels, and long-term use lowers vitamin B12. Confirm anything specific with your pharmacist.

• ● iodinated contrast media (CT and angiography dye) (iodinated radiocontrast) : lactic acidosis. the label advises withholding metformin at or before the procedure in at-risk patients and restarting after 48 hours once kidney function is confirmed stable. [Glucophage (metformin) US Prescribing Information, Warnings and Drug Interactions]
• ● alcohol (alcohol) : increased risk of lactic acidosis, and hypoglycemia with heavy or acute intake. avoid excessive alcohol. [Glucophage (metformin) US Prescribing Information, Warnings and Drug Interactions]
• ● carbonic anhydrase inhibitors (topiramate, acetazolamide, zonisamide, dichlorphenamide) (carbonic anhydrase inhibitor) : increased risk of lactic acidosis. the label advises considering more frequent monitoring. [Glucophage (metformin) US Prescribing Information, Warnings and Drug Interactions]
• ● drugs that reduce renal clearance (cimetidine, dolutegravir, ranolazine, vandetanib, trimethoprim) (renal cation transporter (OCT2/MATE) inhibitor) : higher metformin exposure and lactic acidosis risk. monitor; a dose adjustment may be needed. [Glucophage (metformin) US Prescribing Information, Warnings and Drug Interactions]
• ● insulin and insulin secretagogues (sulfonylureas) (antidiabetic) : hypoglycemia. the companion drug may need a lower dose. [Glucophage (metformin) US Prescribing Information, Warnings and Drug Interactions]
• ● vitamin B12 (nutrient) : B12 deficiency over time, which can cause anemia and nerve symptoms. periodic B12 testing during long-term use, and supplementation if low. [Glucophage (metformin) US Prescribing Information, Warnings and Drug Interactions]

A potent MAO-A inhibitor. Combining it with SSRIs, SNRIs, MAOIs or other serotonergic drugs can precipitate serotonin syndrome, the single most important risk. Contraindicated in G6PD deficiency (acute red-cell breakdown) and avoided in pregnancy, with a narrow dose window in which high doses cause the very methemoglobinemia the drug treats.

• ● SSRIs and SNRIs (serotonergic antidepressant) : serotonin syndrome, a potentially life-threatening reaction with agitation, high fever, muscle rigidity and unstable vital signs; severe and fatal cases are on record. avoid the combination; needs a clinician-supervised washout, and regulators have warned about it specifically. [Gillman 2011]
• ● MAOIs and other serotonergic agents (MAO inhibitor / serotonergic) : serotonin syndrome. avoid; decisions belong with a clinician who knows all serotonergic medicines. [Gillman 2011]
• ● G6PD deficiency (inherited enzyme deficiency) : acute hemolysis (red-cell breakdown); the drug is also less effective in this setting. screen for G6PD before use; avoid in deficiency, which is common and often undiagnosed. [Clifton 2003 (Am J Ther review)]
• ● pregnancy and breastfeeding (reproductive state) : potential fetal harm; safety in breastfeeding is not established. avoid outside a clear medical emergency and without direct medical guidance. [Sacred Lotus: Methylene Blue, Cautions]

Ginseng may reduce the effect of warfarin, which is high-stakes for anyone relying on it. It can lower blood sugar, so it stacks with diabetes medication; it has documented interactions with MAOIs; and its immunostimulant activity may oppose immunosuppressants. It can also cause stimulation and raise blood pressure, and is avoided in pregnancy and hormone-sensitive conditions.

• ● warfarin (anticoagulant (vitamin K antagonist)) : reduced INR and loss of anticoagulation control. tell the clinician who manages your INR before starting ginseng so your levels can be watched. [Izzo & Ernst 2009 (systematic review)]
• ● antidiabetic medication (insulin, sulfonylureas) (antidiabetic) : additive hypoglycemia risk when taken with diabetes medication. raise it with your clinician and keep an eye on your readings when you start or stop. [Izzo & Ernst 2009 (systematic review)]
• ● MAOIs such as phenelzine (MAO inhibitor) : insomnia, headache, tremor and manic-like symptoms. avoid combining; tell the prescriber managing the MAOI. [Izzo & Ernst 2009 (systematic review)]
• ● immunosuppressants (immunosuppressant) · theoretical : possible reduced effect of an immunosuppressant. caution in transplant or autoimmune therapy; check with the clinician managing it. [Sacred Lotus: Panax Ginseng, Cautions (other medicines)]
• ● antihypertensive medication (antihypertensive) · theoretical : possible reduced blood-pressure control or restlessness. discuss first if your blood pressure is poorly controlled; take it earlier in the day and start low. [Sacred Lotus: Panax Ginseng, Cautions]
• ● pregnancy, breastfeeding and hormone-sensitive conditions (reproductive / hormonal state) · theoretical : not recommended in pregnancy or breastfeeding; caution with hormone-sensitive conditions. avoid in pregnancy and breastfeeding; get a clinician view for a hormone-sensitive condition. [Sacred Lotus: Panax Ginseng, Cautions]

Well tolerated in healthy people. The serious documented risk is that live organisms can cross into the bloodstream in the immunocompromised, the critically ill, or those with a central venous line, so a probiotic is a medical decision in those groups. A bacterial probiotic should also be spaced from antibiotic doses.

• ● immunosuppressant medication and immunocompromising treatment (immunosuppressant) : risk of systemic bacterial infection or yeast fungemia; in one trial of critically ill pancreatitis patients a probiotic mixture was linked to more deaths. for anyone immunocompromised, critically ill, or with a central line, treat a probiotic as a medical decision to make with a clinician rather than a self-care one. [Besselink 2008, PROPATRIA trial (Lancet)]
• ● antibiotics (antibiotics) : reduced viability of a bacterial probiotic if taken together. separate a bacterial probiotic from the antibiotic dose by about two hours; Saccharomyces boulardii is a yeast and is unaffected, so it can be taken at any time. [Hempel 2012]

Sirolimus is metabolized by CYP3A4 and carried by P-glycoprotein, so its blood levels swing widely with inhibitors and inducers, including grapefruit. It suppresses the immune system, so it stacks with other immunosuppressants and makes live vaccines both less effective and potentially unsafe. Use requires blood-level monitoring under a clinician. Confirm anything specific with your pharmacist.

• ● CYP3A4 / P-glycoprotein inhibitors (ketoconazole and other azole antifungals, clarithromycin, ritonavir, diltiazem, verapamil) (CYP3A4/P-gp inhibitor) : sirolimus toxicity. the label does not recommend strong inhibitors such as ketoconazole; otherwise monitor sirolimus levels closely. [Rapamune (sirolimus) US Prescribing Information, Drug Interactions]
• ● grapefruit and grapefruit juice (dietary CYP3A4 inhibitor) : increased sirolimus exposure. the label advises not taking sirolimus with grapefruit juice. [Rapamune (sirolimus) US Prescribing Information, Drug Interactions]
• ● CYP3A4 / P-gp inducers (rifampin, rifabutin, carbamazepine, phenytoin, phenobarbital, St John's wort) (CYP3A4/P-gp inducer) : loss of efficacy, including transplant rejection risk. the label does not recommend rifampin; avoid inducers or monitor levels. [Rapamune (sirolimus) US Prescribing Information, Drug Interactions]
• ● other immunosuppressants (cyclosporine, tacrolimus, corticosteroids) (immunosuppressant) : increased infection risk, and altered sirolimus levels with cyclosporine. specialist supervision; the label directs taking sirolimus 4 hours after cyclosporine. [Rapamune (sirolimus) US Prescribing Information, Drug Interactions]
• ● live vaccines (live attenuated vaccine) : reduced vaccine effectiveness and possible vaccine-strain infection. avoid live vaccines during treatment. [Rapamune (sirolimus) US Prescribing Information, Drug Interactions]

The firm caution is pregnancy: high doses stimulate the uterus, so supplement doses are avoided. Saffron acts partly on the serotonin system, so combining it with antidepressants is a clinician decision, and high doses can promote bleeding. It is genuinely toxic in gram-scale overdose, so keep to the studied ~30 mg a day.

• ● SSRIs, SNRIs and other serotonergic drugs (serotonergic antidepressant) · theoretical : additive serotonergic effect in principle; some trials combined them deliberately and safely under supervision. do not add it quietly; tell whoever prescribes your medication so the combination is supervised. [Marx 2019]
• ● anticoagulants and antiplatelets (anticoagulant / antiplatelet) · theoretical : possible increased bleeding risk at high doses. keep to the studied ~30 mg a day and use caution alongside blood thinners. [Sacred Lotus: Saffron, Cautions]
• ● pregnancy and breastfeeding (reproductive state) : uterine stimulation; treated as unsafe in pregnancy in both the herbal tradition and modern cautions. keep to culinary food amounts at most in pregnancy and do not take the supplement; best avoided while breastfeeding. [Sacred Lotus: Saffron, Cautions (pregnancy)]

The senolytic agents range from dasatinib, a prescription leukemia chemotherapy, to the flavonoids quercetin and fisetin. Dasatinib is a CYP3A4 substrate whose levels rise with inhibitors (including grapefruit) and fall with inducers; it lowers platelet counts and can prolong the QT interval, and navitoclax also lowers platelets, so both add to bleeding risk. Quercetin can inhibit drug-metabolizing enzymes and transporters and change the levels of other medicines. Confirm anything specific with your pharmacist.

• ● CYP3A4 inhibitors, including grapefruit (ketoconazole and other azoles, clarithromycin, ritonavir) (CYP3A4 inhibitor) : increased dasatinib toxicity. avoid strong inhibitors and grapefruit, or the oncologist adjusts the dose. [Sprycel (dasatinib) US Prescribing Information, Warnings and Drug Interactions]
• ● CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort, dexamethasone) (CYP3A4 inducer) : loss of dasatinib efficacy. avoid inducers; choose a non-inducing alternative. [Sprycel (dasatinib) US Prescribing Information, Warnings and Drug Interactions]
• ● anticoagulants and antiplatelet drugs (anticoagulant/antiplatelet) : increased bleeding. avoid or monitor closely under specialist care. [Sprycel (dasatinib) US Prescribing Information, Warnings and Drug Interactions]
• ● QT-prolonging medicines (certain antiarrhythmics, some antipsychotics, methadone) (QT-prolonging drug) : additive QT prolongation and arrhythmia risk. correct low potassium and magnesium, and use caution with other QT-prolonging drugs. [Sprycel (dasatinib) US Prescribing Information, Warnings and Drug Interactions]
• ● CYP3A4 and P-glycoprotein substrate drugs (for example cyclosporine) (CYP3A4/P-gp substrate) · theoretical : possible increased exposure to substrate drugs. check interactions with a pharmacist before combining. [Izzo 2014, cyclosporine and herbal supplement interactions review (quercetin CYP3A4/P-gp)]

SGLT2 inhibitors act as a mild diuretic, so with loop or thiazide diuretics they can cause volume depletion and low blood pressure, especially in older adults. With insulin or a sulfonylurea they can cause hypoglycemia. They can cause ketoacidosis even at near-normal blood sugar, so they are paused around surgery and serious illness, and they can lower lithium levels. Confirm anything specific with your pharmacist.

• ● diuretics (loop and thiazide) (diuretic) : volume depletion and low blood pressure, especially in older adults. assess volume status; the prescriber may adjust diuretic doses and advises staying hydrated. [Jardiance (empagliflozin) US Prescribing Information, Drug Interactions]
• ● insulin and insulin secretagogues (sulfonylureas) (antidiabetic) : hypoglycemia; note that over-aggressive insulin reduction can raise the risk of euglycemic ketoacidosis. the companion drug may need a lower dose, adjusted by the prescriber. [Jardiance (empagliflozin) US Prescribing Information, Drug Interactions]
• ● lithium (mood stabilizer (narrow therapeutic index)) : reduced lithium effectiveness. monitor lithium levels more often when starting or stopping the SGLT2 inhibitor. [Jardiance (empagliflozin) US Prescribing Information, Drug Interactions]

The central safety issue with shilajit is contamination: as a raw mineral resin it can carry lead, arsenic, mercury and cadmium, so only purified, third-party-tested product is appropriate. It also contains iron (a concern in iron overload) and can affect testosterone and blood sugar, so it needs care alongside hormone therapy, iron supplements, and diabetes medication. Confirm with your pharmacist.

• ● iron supplements : added iron can accumulate in hereditary hemochromatosis or another iron-overload condition and cause harm. if you have an iron-overload disorder, discuss shilajit with the clinician managing it rather than adding it on your own. [Shilajit page, Cautions (iron overload and hemochromatosis)]
• ● hormone therapy (hormone therapy) · theoretical : a possible shift in hormone levels. raise it with your clinician before combining. [Shilajit page, Cautions (medications and existing conditions)]
• ● diabetes medications (antidiabetic) · theoretical : a possible additive change in blood glucose. monitor glucose and check with a clinician if you take diabetes medication. [Shilajit page, Cautions (medications and existing conditions)]

Plasma exchange is non-selective: it strips protein-bound drugs, monoclonal antibodies and clotting factors out of the blood, so this is a genuinely higher-interaction procedure. Time drug doses around sessions and expect a transient dip in clotting factors afterward. Confirm any medication schedule with your pharmacist and the apheresis team.

• ● monoclonal antibodies and biologics (e.g. rituximab, other antirheumatic biologics) (monoclonal antibody / biologic) : reduced circulating drug level and possible loss of therapeutic effect. schedule dosing after a session and time the infusion course around the exchange schedule, guided by each drug's pharmacokinetics. [Ding 2026]
• ● anticoagulants and clotting factors (e.g. warfarin, apixaban) (anticoagulant) : transient shift in bleeding risk and in anticoagulant level around sessions. monitor coagulation and time anticoagulant dosing with the apheresis team. [Doborjginidze 2024]
• ● ACE inhibitors (ACE inhibitor) : facial flushing, warmth, bradycardia and hypotension (anaphylactoid reaction) during the procedure. hold the ACE inhibitor before apheresis if the unit advises, and switch classes where needed. [Siami 1997]

One interaction matters: warfarin and other vitamin K antagonists work by blocking vitamin K, so a K2 supplement is their direct counterweight and can blunt the drug and swing the INR out of range. Otherwise K2 is well tolerated at microgram MK-7 doses with no established toxic upper level.

• ● warfarin and other vitamin K antagonists (vitamin K antagonist / anticoagulant) : blunts the anticoagulant and can swing the INR out of range, reducing anticoagulation and destabilising control. do not start, stop or change a K2 supplement without the prescriber who manages your INR; consistency is what keeps these drugs safe. [FDA warfarin (Coumadin) prescribing information, vitamin K antagonism]

Blunts the post-meal glucose rise, so it can add to insulin or sulfonylureas and push blood sugar too low; its potassium-lowering potential from heavy chronic intake can add to diuretics and raise the risk of digoxin toxicity. Confirm with your pharmacist if you take these.

• ● insulin and sulfonylureas (antidiabetic) · theoretical : risk of blood sugar dropping too low (hypoglycemia). monitor blood glucose and clear a daily habit with the prescriber. [Johnston 2004]
• ● diuretics (diuretic) · theoretical : low potassium (hypokalemia). avoid large daily intake; monitor potassium if combined. [Lhotta 1998 (case report)]
• ● digoxin (cardiac glycoside) · theoretical : increased risk of digoxin toxicity. avoid large daily intake; monitor potassium and digoxin with the prescriber. [Lhotta 1998 (case report)]

CoQ10 is one of the better-tolerated supplements. Its one interaction to watch is with warfarin: CoQ10 is structurally similar to vitamin K and case reports describe it lowering the INR, though a randomized crossover trial found no change, so the interaction is not established. It is an add-on, not a replacement for any heart medicine. Confirm with your pharmacist.

• ● warfarin (anticoagulant (vitamin K antagonist)) · theoretical : a lower INR would make warfarin less effective at preventing clots; one randomized crossover trial found no change in dose or INR, so this is a watch-point rather than an established interaction. tell whoever manages your warfarin dose before starting, so your INR can be checked while you settle in. [Engelsen 2002 (Thromb Haemost), randomized crossover]

Quercetin affects CYP enzymes and P-glycoprotein and can alter the levels of co-taken drugs; it has antiplatelet activity, can add to blood-pressure medicines, and animal data flag caution in an already-injured kidney. Fisetin is assumed to share the low absorption but has little interaction data. Confirm with your pharmacist.

• ● CYP3A4 and P-glycoprotein substrate drugs (various) · theoretical : altered (usually raised) levels of some prescription drugs. have a pharmacist check for interactions before a supplement dose if you take prescription drugs. [Andres 2018 (safety review)]
• ● anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel) (anticoagulant / antiplatelet) · theoretical : increased bleeding risk. tell the prescriber before combining, especially around surgery. [Pace-Asciak 1995]
• ● blood-pressure medications (antihypertensive) · theoretical : additive blood-pressure lowering. monitor blood pressure and decide with the prescriber. [Serban 2016 (meta-analysis)]
• ● existing kidney disease / nephrotoxic drugs (nephrotoxic) · theoretical : potential added kidney stress in existing renal impairment. check with the clinician managing kidney disease before high-dose use; this is a check-first situation rather than a flat prohibition. [Andres 2018 (safety review)]

Greens powders built on leafy greens carry vitamin K, so starting or stopping a daily scoop can move the INR of someone on warfarin; the fix is steadiness. Many also pack a full multivitamin dose plus iron, vitamin A and iodine from kelp, which stack with other supplements. Algae ingredients can carry contaminants, so third-party testing matters. Confirm with your pharmacist.

• ● warfarin (anticoagulant (vitamin K antagonist)) : starting or stopping a daily scoop can move the INR. keep intake steady rather than avoiding it, and tell whoever manages your INR before adding or stopping a daily scoop. [Dietary vitamin K and vitamin K antagonists 2016 (Medicine)]
• ● multivitamins and other supplements : fat-soluble vitamins, iron and iodine can add up past intended amounts, and kelp iodine can push iodine high enough to affect the thyroid. total your intake across everything you take rather than looking at each product alone; watch kelp iodine if you have thyroid concerns. [Greens powders page, Cautions (watch the stacked totals)]

These compounds raise growth hormone and IGF-1, which raises blood glucose and lowers insulin sensitivity, so they can work against antidiabetic drugs and worsen glucose control. Most are sold as unapproved research chemicals with no check on identity, dose, purity, or sterility, which is a sourcing hazard rather than a pharmacologic drug interaction. Confirm anything specific with your pharmacist.

• ● antidiabetic medicines (insulin, metformin, sulfonylureas) (antidiabetic) : worsened glycemic control, which can reduce the effect of antidiabetic treatment. monitor blood glucose, and a clinician may adjust antidiabetic doses. [Nass 2008 (ibutamoren, glucose and insulin sensitivity)]

Iron binds several medicines and minerals in the gut and lowers absorption on both sides, most importantly levothyroxine and certain antibiotics, so separate them by several hours. Calcium blunts iron uptake, while vitamin C boosts it. Confirm with your pharmacist.

• ● levothyroxine (thyroid hormone) : reduced thyroxine efficacy, which can worsen hypothyroid control. separate iron and levothyroxine by several hours and tell your clinician what you take. [Campbell 1992 (Ann Intern Med)]
• ● tetracycline and fluoroquinolone antibiotics (antibiotic) : reduced antibiotic absorption and effectiveness. separate iron from the antibiotic dose by a few hours. [Iron page, Cautions (timing, interactions)]
• ● calcium supplements : lower iron uptake when the two are taken together. space iron and calcium apart, and keep calcium-rich foods for between meals when building stores. [Iron page (how to take it so you absorb it)]
• ● vitamin C : increased iron absorption from plant foods. a useful pairing for building stores; a point of care for anyone with iron overload. [Iron page (how it works)]

At approved antiparasitic doses ivermectin has few clinically important drug interactions. It is a substrate of CYP3A4 and P-glycoprotein, so strong inhibitors could in theory raise its levels and central-nervous-system exposure; isolated case reports describe raised INR with warfarin; and combining with other CNS depressants is a theoretical additive concern, mainly in overdose. The Loa loa co-infection reaction in endemic regions is a parasite issue, not a drug interaction. Confirm anything specific with your pharmacist.

• ● strong CYP3A4 / P-glycoprotein inhibitors (ketoconazole, ritonavir, clarithromycin) (CYP3A4/P-gp inhibitor) · theoretical : increased risk of ivermectin side effects. use caution; a prescriber weighs the combination. [Stromectol (ivermectin) US Prescribing Information]
• ● warfarin (anticoagulant) · theoretical : possible increased anticoagulant effect and bleeding. monitor INR if the two are combined. [Stromectol (ivermectin) US Prescribing Information]
• ● other central nervous system depressants (benzodiazepines, barbiturates) (CNS depressant) · theoretical : possible additive sedation, mainly a concern in overdose. caution at high doses. [Stromectol (ivermectin) US Prescribing Information]

Interactions are thin and theoretical: early lab and animal work suggests a mild blood-thinning action and a slight blood-sugar lowering effect. As a mushroom it can cause allergic and, rarely, breathing reactions, so start with a small amount.

• ● anticoagulants and antiplatelets (anticoagulant / antiplatelet) · theoretical : possible additive bleeding risk. raise with the clinician managing your blood thinner, and stopping about two weeks before planned surgery is a sensible precaution. [Sacred Lotus: Lion's Mane, Cautions]
• ● antidiabetic medication (antidiabetic) · theoretical : possible additive blood-sugar lowering. if you take medication for diabetes, raise it with the clinician who manages that before starting. [Sacred Lotus: Lion's Mane, Cautions]

Well tolerated in people with normal kidney function. It can bind several oral medicines in the gut and lower their absorption, so spacing the doses is the fix; certain long-term medicines lower body magnesium; and it can build up when kidney function is reduced.

• ● levothyroxine (thyroid hormone) : reduced thyroid hormone absorption and a weaker dose. take levothyroxine at least four hours apart from magnesium. [FDA levothyroxine prescribing information]
• ● tetracycline and quinolone antibiotics (antibiotics) : reduced antibiotic absorption and effect. take the antibiotic at least two to four hours apart from magnesium. [FDA ciprofloxacin prescribing information]
• ● bisphosphonates (bisphosphonate) : reduced bisphosphonate absorption. separate dosing by at least a few hours as the drug label directs. [FDA alendronate prescribing information]
• ● proton pump inhibitors (proton pump inhibitor) : low blood magnesium (hypomagnesemia) with prolonged use; this lowers magnesium rather than raising it. clinicians may monitor magnesium during long-term PPI therapy. [FDA proton pump inhibitor class drug safety communication]
• ● loop and thiazide diuretics (diuretic) : loop and thiazide diuretics can lower body magnesium over time; potassium-sparing diuretics can raise it, which matters more when kidney function is reduced. clinicians may monitor and replace magnesium with long-term diuretic use. [Natural Medicines Comprehensive Database]

Reishi has antiplatelet/antithrombotic activity that can add to blood thinners; the group's immune-stimulating action is a theoretical concern with immunosuppressant drugs and autoimmune disease. Turkey tail belongs alongside cancer chemotherapy only under an oncologist, never as a substitute. Confirm with your clinician.

• ● anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel) (anticoagulant / antiplatelet) · theoretical : increased bleeding risk, including around surgery. tell the clinician you take a mushroom supplement; pause before surgery. [Kumaran 2011]
• ● immunosuppressant drugs (immunosuppressant) · theoretical : possible reduced drug effect or unwanted immune activation. clear with the clinician managing an immunosuppressant, transplant, or autoimmune condition before use. [Jin 2016 (Cochrane review)]

A circadian timing signal rather than a sedative. It carries documented cautions with blood thinners, immunosuppressant medicines, sedatives and alcohol, and drugs that affect the liver enzyme (CYP1A2) that clears it, and it may interact with blood-pressure and diabetes medicines.

• ● warfarin and antiplatelet drugs (anticoagulant / antiplatelet) · theoretical : possible increased bleeding risk. check with a clinician or pharmacist before combining with a blood thinner. [Natural Medicines Comprehensive Database]
• ● immunosuppressant medication (immunosuppressant) · theoretical : may reduce the intended effect of immunosuppressant treatment. avoid, or use only under the clinician managing that therapy. [Natural Medicines Comprehensive Database]
• ● sedatives, sleep medicines and alcohol (sedative / CNS depressant) · theoretical : increased drowsiness and next-day grogginess. use caution combining, and avoid driving until you know how it affects you. [Natural Medicines Comprehensive Database]
• ● fluvoxamine and other CYP1A2 inhibitors (CYP1A2 inhibitor) : markedly increased melatonin exposure with more grogginess. avoid the combination, or lower the dose under clinician guidance. [Natural Medicines Comprehensive Database]
• ● antihypertensive medication (antihypertensive) · theoretical : a small change in blood-pressure control. mention it to the clinician managing blood-pressure treatment. [Natural Medicines Comprehensive Database]
• ● diabetes medication (antidiabetic) · theoretical : a small change in blood-sugar control. mention it to the clinician managing diabetes treatment. [Natural Medicines Comprehensive Database]

N-acetylcysteine is the hospital antidote for acetaminophen overdose, a supervised high-dose treatment separate from any supplement use; an overdose is an emergency, not a supplement question. As a supplement NAC may add to nitrate vasodilators, blood thinners and blood-pressure drugs, mainly at the gram-scale doses of the GlyNAC protocol. The inhaled form can provoke bronchospasm in asthma.

• ● nitroglycerin and other nitrates (nitrate vasodilator) : enhanced hypotension and headache. combine only under clinician oversight; the risk is greatest at higher doses. [Boesgaard 2002 (Eur J Pharmacol)]
• ● anticoagulants and antiplatelets (anticoagulant / antiplatelet) · theoretical : possible additive bleeding risk; NAC is sometimes paused before surgery. tell the clinician managing you, and flag any upcoming surgery; this matters most at gram-scale combination doses. [Sacred Lotus: NAC and Glycine, Cautions]
• ● antihypertensive medication (antihypertensive) · theoretical : possible additive blood-pressure lowering. tell the clinician who prescribes your blood-pressure medication. [Sacred Lotus: NAC and Glycine, Cautions]

Well tolerated at food and standard supplement doses. The documented risks belong mainly to the 4 g prescription dose: a small, dose-related rise in atrial fibrillation, an irregular heartbeat, and a small bleeding signal. A standard 1 g capsule showed no excess bleeding in the large trials.

• ● warfarin and other anticoagulant or antiplatelet drugs (anticoagulant / antiplatelet) : possible increased bleeding risk, mainly at the 4 g prescription dose; a standard 1 g dose showed no excess bleeding in the large trials. tell your clinician you take omega-3 before surgery or if you take an anticoagulant, since it is simple to pause beforehand. [Bhatt 2019, REDUCE-IT]
• ● curcumin · theoretical : a small additive effect on bleeding tendency when combined. worth noting if you also take a blood thinner or have surgery coming up. [Natural Medicines Comprehensive Database]

Peptides span approved, tested drugs (the GLP-1 medicines and insulin) and a large grey market of research peptides. Their pharmacologic interactions belong to the specific compound: the GLP-1 peptides lower blood sugar (see glp-1-agonists) while the growth-hormone peptides raise it (see growth-hormone-secretagogues). For the unapproved research peptides the dominant hazard is not a drug interaction but product purity, sterility, and contamination, together with the risks of self-injection. Confirm anything specific with your pharmacist.

• ● antidiabetic medicines (insulin, sulfonylureas) (antidiabetic) : hypoglycemia with GLP-1 peptides, or worsened control with growth-hormone peptides, depending on which peptide. the interaction is specific to the peptide; see the glp-1-agonists and growth-hormone-secretagogues pages and confirm with a prescriber. [Ozempic (semaglutide) US Prescribing Information, Drug Interactions]

Has antiplatelet activity and, in the laboratory, inhibits CYP3A4 and CYP2C9, so it may add to blood thinners and antiplatelets and raise levels of drugs cleared by those enzymes. Human interaction data are limited; confirm with your pharmacist, especially before surgery.

• ● anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel) (anticoagulant / antiplatelet) · theoretical : increased bleeding risk, and an additive effect around surgery. tell the prescriber before combining; consider pausing before surgery. [Pace-Asciak 1995]
• ● CYP3A4 and CYP2C9 substrate drugs (various) · theoretical : potentially raised blood levels of some prescription drugs. raise with a pharmacist if you take regular medication. [Detampel 2012 (review)]

Rhodiola is activating and has a mood effect in some trials, so the concern is additive effects with antidepressants, stimulants, and other mood medication. It is also worth raising before combining with tightly-dosed medicines for blood pressure, blood sugar, or blood thinning. Confirm with your pharmacist.

• ● antidepressants (antidepressant) · theoretical : effects on mood and activation could stack. take care combining and raise it with your clinician or pharmacist first. [Rhodiola page, Cautions (it may interact with some medications)]
• ● stimulants (stimulant) · theoretical : additive stimulation, jitteriness or restlessness. take care combining, keep dosing to the morning, and start at the lower end of the range. [Rhodiola page, Cautions (it is stimulating)]
• ● medicines with a narrow safety margin (blood pressure, blood sugar, blood thinners) · theoretical : a possible change in the effect of a medicine with little margin for error. check with a clinician or pharmacist before combining rather than after. [Rhodiola page, Cautions (it may interact with some medications)]

Taurine modestly lowers blood pressure (about 3 mmHg) and improves glycemic control in diabetes, so it can stack with blood-pressure and diabetes medication and is worth watching if you are medicated. It is cleared by the kidneys, so reduced kidney function is a check-first situation. Well tolerated to about 3 g a day.

• ● antihypertensive medication (antihypertensive) : additive blood-pressure lowering. tell the clinician who tracks your numbers and keep an eye on your readings rather than adding it silently. [Waldron 2018]
• ● antidiabetic medication (antidiabetic) : additive blood-sugar lowering, could push glucose lower than intended. raise it with the clinician who prescribes your diabetes medication and monitor your readings. [Sacred Lotus: Taurine (glycemic meta-analysis of 5 RCTs)]
• ● kidney disease or reduced renal function (renal impairment) · theoretical : unstudied handling in reduced kidney function. a check-first situation rather than a flat prohibition; discuss with the clinician who manages your kidneys or dialysis. [Sacred Lotus: Taurine, Cautions]

Shifts testosterone and related hormones, so it warrants caution in hormone-sensitive conditions and fertility treatment; its usual stack partner Fadogia agrestis has no human data and an animal testicular-toxicity signal. Trials were short and in healthy men, so its profile alongside chronic medication is not characterised. Confirm with your clinician.

• ● fadogia-agrestis (herbal supplement (common stack partner)) · theoretical : potential reproductive and organ toxicity (animal evidence only). avoid the stack; keep to tongkat ali alone while human safety data for Fadogia are absent. [Yakubu 2005 (rat study)]
• ● hormone-sensitive conditions and fertility treatment (hormonal therapy) · theoretical : unpredictable interaction with hormone-sensitive disease or hormonal/fertility treatment. raise with the clinician before use rather than adding it silently. [Talbott 2013]
• ● regular prescription medication / chronic conditions (various) · theoretical : unknown interaction profile with chronic medication. tell the clinician who oversees your medication before adding it; keep to the standardized extracts and doses used in research. [Chinnappan 2021]

Turmeric as a cooking spice is well tolerated and not the concern; concentrated, absorption-enhanced extracts are. At supplement doses curcumin can add to blood-thinning medication, can trouble a gallbladder or blocked bile duct, and has rarely been linked to liver injury.

• ● warfarin, clopidogrel and daily aspirin (anticoagulant / antiplatelet) : possible increased bleeding risk; turmeric in food is not the concern, concentrated capsules are. raise turmeric supplements with the clinician managing that treatment before starting, and before any surgery. [Natural Medicines Comprehensive Database]
• ● other hepatotoxic agents (hepatotoxic agents) : risk of liver injury, which may matter alongside other liver-stressing medicines. check with a clinician before using a concentrated supplement if you have a liver condition or take a daily medication; cooking with turmeric is not the concern. [Natural Medicines Comprehensive Database]
• ● omega-3-fish-oil · theoretical : a small additive effect on bleeding tendency when combined. worth noting if you also take a blood thinner or have surgery coming up. [Natural Medicines Comprehensive Database]

B12 itself is very safe. The interactions run the other way: metformin and long-term acid-blocking drugs deplete B12 over years, and high folate intake can mask a B12-deficiency anaemia while nerve damage continues. Test rather than guess. Confirm with your pharmacist.

• ● metformin (biguanide (antidiabetic)) : blood B12 fell about 19% over four years, making long-term users a defined at-risk group for deficiency. a periodic B12 check for long-term users, especially alongside age or a low-animal-food diet; correct a confirmed shortfall. [de Jager 2010 (BMJ)]
• ● proton-pump inhibitors and other acid blockers (proton-pump inhibitor) : a slow, silent decline in B12 status. a periodic B12 check for long-term users; correct a confirmed deficiency with a plan that fits the cause. [Vitamin B12 page, Cautions (long-term metformin or acid-blocker users)]
• ● high-dose folic acid : the anaemia is hidden while neurological harm progresses, delaying diagnosis. check B12 directly rather than inferring it from a blood count; test before relying on high-dose folate. [Vitamin B12 page, Cautions (folate can hide the anaemia)]

Vitamin C increases iron absorption, which is useful on a plant-based diet but a risk for anyone with iron overload. At high doses it can also make some blood-glucose meters read falsely high, so a reading can be unreliable for insulin decisions. Confirm with your pharmacist.

• ● iron : enhanced iron absorption, which is helpful for low iron but can worsen iron overload. useful when paired with plant iron at a meal; anyone with hereditary hemochromatosis or iron overload should avoid high-dose vitamin C and deliberate pairing with iron. [Vitamin C page, Cautions (iron overload: hemochromatosis)]
• ● insulin dosing guided by blood-glucose meters (insulin) : a falsely high reading could prompt an incorrect insulin dose. do not adjust insulin on a suspect value; tell whoever orders a glucose test that you take vitamin C. [Vitamin C page, Cautions (it can throw off a glucose meter)]

Few drug interactions at sensible daily doses. The main safety concern is sustained high-dose intake raising blood calcium (hypercalcemia), which matters most alongside conditions or medicines that also raise calcium. People with sarcoidosis or primary hyperparathyroidism should supplement only under medical guidance.

• ● thiazide diuretics (thiazide diuretic) : raised blood calcium (hypercalcemia), mainly with high-dose vitamin D. monitor blood calcium when combining high-dose vitamin D with a thiazide diuretic. [FDA hydrochlorothiazide prescribing information]

Zinc binds some antibiotics in the gut and lowers how much drug is absorbed, so space them apart. Sustained high-dose zinc competes with copper for absorption and can cause copper deficiency, and at high intake it competes with iron too. Keep daily intake under about 40 mg. Confirm with your pharmacist.

• ● tetracycline antibiotics (tetracycline antibiotic) : tetracycline absorption fell by around a third in one study. take zinc two to three hours apart from the antibiotic dose. [Penttila 1975 (Eur J Clin Pharmacol)]
• ● fluoroquinolone antibiotics (fluoroquinolone antibiotic) : reduced antibiotic absorption and effectiveness. take zinc two to three hours apart from the dose. [Zinc page, Cautions (space it away from certain antibiotics)]
• ● copper : copper deficiency causing anaemia and nerve damage that may not fully reverse. keep sustained intake under about 40 mg of elemental zinc a day; have a clinician monitor copper if you supplement heavily long-term. [Duncan 2015 (J Clin Pathol)]
• ● iron : reduced iron absorption when zinc is taken at high doses. keep zinc doses modest and space high-dose minerals apart. [Zinc page, Cautions and How It Works]

Lab panels are not a treatment, so there is no pharmacologic drug interaction. The genuine, documented issue is assay interference: high-dose biotin (vitamin B7) supplements distort many immunoassays that rely on biotin-streptavidin binding, which can produce falsely high or low results across a range of tests including thyroid, hormones and troponin. Tell the lab about any supplements and confirm timing with your clinician.

• ● biotin (vitamin B7) supplements (vitamin supplement) : falsely high or low results across many assays, including thyroid function, hormone and troponin tests. stop high-dose biotin for 2 to 3 days before testing and inform the laboratory. [Colon 2018]

Not a drug interaction risk. The real limits are that it is a dairy product: unsafe with a cow's milk allergy, may cause symptoms in lactose intolerance, and is not a vegan option. Safety in pregnancy, in immunocompromised people, and in active illness is not well studied. Dairy allergy is a food-allergy contraindication, not a pharmacologic interaction.

Interactions are minor. Flavanol-rich cocoa lowers blood pressure a couple of points, a small nudge worth mentioning if you run low or take blood-pressure medication. Cocoa also carries caffeine and theobromine, which can affect sleep and stack with other caffeine, and dark chocolate can carry cadmium and lead.

• ● antihypertensive medication (antihypertensive) · theoretical : modest additive blood-pressure lowering. small for most people; mention a daily flavanol dose to your clinician if your pressure already runs low or is medicated. [Ried 2017 (Cochrane)]
• ● caffeine and other stimulants (stimulant) · theoretical : additive stimulant load that can affect sleep, reflux or a sensitive stomach. account for it if you are already limiting caffeine; keep cocoa and chocolate away from pets, for whom theobromine is toxic. [Sacred Lotus: Cocoa Flavanols, Cautions]

Generally well tolerated, with no significant drug interactions. The real cautions are practical: marine collagen should be avoided by anyone with a fish or shellfish allergy, the source (bovine, porcine or marine) matters for dietary and religious reasons, supplements are loosely regulated so a third-party-tested product is best, and collagen is an incomplete protein that should not replace a full serving of protein.

Generally well tolerated, with one of the longest safety records of any supplement. It raises serum creatinine, the lab marker used to estimate kidney function, without harming the kidney in healthy people, so existing kidney disease is a check-first situation and lab results should be interpreted with that in mind.

• ● nephrotoxic medications (nephrotoxic agents) · theoretical : the creatinine reading can rise without kidney harm, which may complicate monitoring; caution is warranted where kidney function is already reduced. if you have kidney disease, are on dialysis, or take medication that affects the kidney, check with the clinician who manages that before starting; tell anyone ordering a creatinine test that you take creatine, or ask for a cystatin C measure, which creatine does not disturb. [Kreider 2017]

Wellness IV drips and NAD+ infusions have minimal documented pharmacologic drug interactions. The real hazards sit elsewhere: the line and sterility (a safety risk, not a drug interaction), G6PD deficiency with high-dose vitamin C, and iron overload if IV iron is given without a true deficiency. A magnesium-containing drip could in theory add to blood-pressure-lowering drugs. Confirm with your pharmacist.

• ● antihypertensives and vasodilators (antihypertensive / vasodilator) · theoretical : possible additive drop in blood pressure. monitor blood pressure during infusion if on these drugs.

Very well tolerated, with trials up to 28 days reporting no more side effects than placebo. The one interaction to note is a mild additive lowering of blood pressure with antihypertensive medication; pregnancy and breastfeeding are untested for a concentrated supplement, and giving it to a child is a clinician-led decision.

• ● antihypertensive medication (antihypertensive) · theoretical : a small additive lowering of blood pressure. mention it to the clinician managing blood-pressure medication so the combined effect is watched. [Natural Medicines Comprehensive Database]

A low-dose daily multivitamin has a long safety record and few drug interactions. The concerns are stacking: laying it on top of separate single-nutrient pills can push fat-soluble vitamins and iron past daily-requirement amounts, and standalone high-dose beta-carotene is a separate product to avoid in smokers. Confirm with your pharmacist.

• ● other single-nutrient supplements (fat-soluble vitamins and minerals) : fat-soluble vitamins and iron can build up beyond daily-requirement amounts. keep total intake near daily requirements; men and postmenopausal women usually choose an iron-free formula unless a clinician identifies a need. [Multivitamin page, Cautions (iron and the fat-soluble upper limits)]
• ● high-dose beta-carotene (in current or former smokers) : raised lung cancer risk in two large trials. current and former smokers should avoid standalone high-dose beta-carotene and vitamin A supplements. [Multivitamin page, Cautions (beta-carotene and smoking)]

No established pharmacologic drug interactions. A theoretical, unresolved concern is that raising NAD+ could feed an existing cancer, so anyone with current or recent cancer should ask their oncologist first; people with kidney or liver disease, in pregnancy or breastfeeding, or on medication for a metabolic condition should check with a clinician. Long-term safety is unstudied.

Ozone therapy has minimal documented pharmacologic drug interaction; route and dose drive its risk. Inhaling ozone is toxic and injecting the gas can cause embolism, but those are procedural safety hazards rather than drug interactions. G6PD deficiency is a relevant state, because oxidative therapies can trigger red-cell breakdown. Confirm with your clinician, especially about G6PD status, before any course.

Prolotherapy and PRP have few pharmacologic drug interactions, and systematic reviews report no serious adverse events. Two practice-specific points are worth noting: anti-inflammatory drugs may blunt the healing response these injections deliberately provoke, and, as with any injection, anticoagulants or antiplatelets raise the chance of injection-site bruising or bleeding. Confirm timing of any of these drugs with the injector.

• ● NSAIDs and corticosteroids (anti-inflammatory) · theoretical : possible reduction in treatment effect. some clinicians advise pausing anti-inflammatories around treatment; decide with the injector.
• ● anticoagulants and antiplatelets (anticoagulant / antiplatelet) · theoretical : increased bruising or bleeding at the injection site. discuss timing of anticoagulant or antiplatelet dosing with the injector before the procedure.

PEMF has minimal pharmacologic drug interaction. The firm caution is device-to-device: a pulsed magnetic field can interfere with the electronics of a pacemaker, implantable defibrillator, neurostimulator or insulin pump, so it should be avoided unless the specific device is cleared by the relevant specialist. It is also best kept away from the abdomen in pregnancy (a state). Confirm with your specialist if you have any implanted electronic device.

No established pharmacologic drug interactions. Most supplements are wheat-germ derived and contain gluten, so they are unsuitable in celiac disease or wheat allergy. Because polyamines support cell growth, anyone with an active cancer should check with their oncology team; anti-aging use is experimental.

For the injectable clinic products (mesenchymal cells, exosomes) there is minimal documented pharmacologic drug interaction; the dominant risks are procedural, including contamination, infection and, with eye injections, permanent vision loss. In the established setting of allogeneic transplant, immunosuppressive drugs are an integral part of care to prevent rejection, which is a treatment requirement rather than an adverse interaction. Confirm any specifics with a clinician who is not selling the product.

No established pharmacologic drug interactions at food or normal supplement doses. Goitrogens in raw crucifers are a theoretical thyroid concern only at very high intake with low iodine, and raw sprouts carry a foodborne-infection risk for pregnant, young, older, or immunocompromised people. Not a treatment for any diagnosed disease.

No characterised drug interactions; formal interaction studies are lacking. Well tolerated over four months at up to 1,000 mg a day. Long-term use over years is unstudied, and there is no trial data in pregnancy or breastfeeding.

• ● prescription medicines generally (unspecified) · theoretical : no interaction is established either way. if you take prescription drugs or manage a chronic condition, a word with your pharmacist before adding a concentrated supplement is sensible. [Sacred Lotus: Urolithin A, Cautions]

Vagus nerve stimulation has minimal pharmacologic drug interaction. The relevant caution is device-to-device and physiologic: because stimulation acts on autonomic pathways that influence heart rate and rhythm, anyone with a pacemaker, an implanted defibrillator or a rhythm disorder should have cardiology review before ear-clip or implanted stimulation. Confirm with your cardiologist if you have an implanted cardiac device.

Whole-body cryotherapy has no meaningful pharmacologic drug interactions. The acute cold raises blood pressure and heart rate on entry, so people on cardiovascular medication or with uncontrolled hypertension should be cleared first, but that is a physiologic caution rather than a drug interaction. Frostbite and, in nitrogen units, asphyxiation are the real hazards. Confirm with your clinician if you have a heart condition.